EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of Intravitreal Faricimab in Patients with Refractory Macular Edema Secondary to Retinal Vein Occlusion, Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration.

Duaa Jabbar Al-Azzawi, Samara Muwafaq Alabdali, Zaid Rajab Al-Alwsi

F1000Research · 11.04.2026 · 15 · 505

DOI: 10.12688/f1000research.178124.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, online erschienen am 11.04.2026. Verfasst von Duaa Jabbar Al-Azzawi und 2 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to evaluate the anatomical and functional outcomes after switching to intravitreal faricimab in patients with refractory macular edema secondary to neovascular age-related macular degeneration (n-AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO).

Methods

This study included 88 eyes from 76 patients with refractory macular edema due to DME, RVO, or active n-AMD. All patients received three consecutive monthly intravitreal faricimab injections. Demographic data and medical history of hypertension and diabetes mellitus were recorded. Best-corrected visual acuity (BCVA), central retinal thickness (CRT), and the presence of intraretinal fluid (IRF) and subretinal fluid (SRF) were assessed using spectral-domain optical coherence tomography at baseline and 16 weeks.

Results

In the DME group, significant improvements were observed in BCVA, CRT, IRF, and SRF (P

Zitieren

APA

Al-Azzawi, D. J., Alabdali, S. M., & Al-Alwsi, Z. R. (2026). Efficacy of Intravitreal Faricimab in Patients with Refractory Macular Edema Secondary to Retinal Vein Occlusion, Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration. F1000Research, 15, 505. https://doi.org/10.12688/f1000research.178124.1

Vancouver

Al-Azzawi DJ, Alabdali SM, Al-Alwsi ZR. Efficacy of Intravitreal Faricimab in Patients with Refractory Macular Edema Secondary to Retinal Vein Occlusion, Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration. F1000Research. 2026;15:505. doi:10.12688/f1000research.178124.1

BibTeX
@article{AlAzzawi2026,
  author = {Al-Azzawi, Duaa Jabbar and Alabdali, Samara Muwafaq and Al-Alwsi, Zaid Rajab},
  title = {Efficacy of Intravitreal Faricimab in Patients with Refractory Macular Edema Secondary to Retinal Vein Occlusion, Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration},
  journal = {F1000Research},
  year = {2026},
  volume = {15},
  pages = {505},
  doi = {10.12688/f1000research.178124.1}
}
Kostenlos starten →